⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL8854303 | 0.79 | — | — | |
| SCHEMBL27928856 | 0.79 | — | — | |
| SCHEMBL23000921 | 0.79 | — | — | |
| SCHEMBL11256487 | 0.77 | — | — | |
| SCHEMBL29956233 | 0.77 | — | — | |
| SCHEMBL93580 | 0.77 | — | — | |
| SCHEMBL31421734 | 0.77 | — | — | |
| SCHEMBL128632 | 0.77 | — | — | |
| SCHEMBL4648822 | 0.77 | — | — | |
| SCHEMBL23312 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0865792-A1 | Pharmaceutical composition containing immunoglobulin for topical use | ROTKREUZSTIFTUNG ZENTRALLABORATORIUM BLUTSPENDEDIENST SRK (CH) | 1998-09-23 | — | — | EP | claimed |
| CN-114213236-A | Synthesis of Yeast dehydrogenase inhibitors | 上海寻科生物医药科技有限公司 | 2022-03-22 | — | — | CN | disclosed |
| US-20120093896-A1 | USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS | CIBA CORPORATION (US) | 2012-04-19 | — | — | US | disclosed |
| US-7871642-B2 | Use of nanodispersions in pharmaceutical end formulations | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2011-01-18 | — | — | US | disclosed |
| EP-2170250-A1 | USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS | BASF SE (DE) | 2010-04-07 | — | — | EP | disclosed |
| WO-2009016064-A1 | USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS | BASF SE (CH) | 2009-02-05 | — | — | WO | disclosed |
| EP-2000131-A2 | Method for applying an active ingredient to a substrate, compositions for said method, receptacle containing a composition and use of said compositions | VESIFACT AG (CH) | 2008-12-10 | — | — | EP | disclosed |
| EP-1385478-B1 | METHOD FOR APPLYING AN ACTIVE INGREDIENT TO A SUBSTRATE, COMPOSITIONS FOR SAID METHOD, CONTAINER CONTAINING A COMPOSITION AND USE OF SAID COMPOSITIONS | VESIFACT AG (CH) | 2008-10-15 | — | — | EP | disclosed |
| US-7381423-B2 | Use of nanodispersions in cosmetic end formulations | CIBA SPECIALTY CHEMICALS CORP. (US) | 2008-06-03 | — | — | US | disclosed |
| US-20060292191-A1 | Use of nanodispersions in pharmaceutical end formulations | CIBA SPECIALITY CHEMICALS CORP. | 2006-12-28 | — | — | US | disclosed |
| US-5658898-A | CONTAINING SPARINGLY WATER SOLUBLE STAUROSPORIN DERIVATIVE, PURE PHOSPHOLIPID, TRIGLYCERIDE, PARTIAL FATTY ACID ESTER OF POLYOXYETHYLENE SORBITAN, WATER | CIBA GEIGY CORPORATION (US) | 1997-08-19 | — | — | US | disclosed |
| WO-1997021428-A1 | CORTISONE SPRAY FOR TOPICAL ADMINISTRATION | VESIFACT AG (CH) | 1997-06-19 | — | — | WO | disclosed |
| WO-1996037192-A1 | PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SPHINGO- AND GLYCOLIPIDS | VESIFACT AG (CH) | 1996-11-28 | — | — | WO | disclosed |
| EP-0733372-A2 | Pharmaceutical base for the formulation of nanosuspensions | CIBA-GEIGY AG (CH) | 1996-09-25 | — | — | EP | disclosed |
| EP-0733358-A2 | Nanosuspensions for intravenous application | CIBA-GEIGY AG (CH) | 1996-09-25 | — | — | EP | disclosed |
| EP-0711557-A1 | Base for formulating pharmaceutical agents | CIBA-GEIGY AG (CH) | 1996-05-15 | — | — | EP | disclosed |
| EP-0711556-A1 | Intravenous solutions containing staurosporine derivatives | CIBA-GEIGY AG (CH) | 1996-05-15 | — | — | EP | disclosed |
| US-5356888-A | Elastase inhibitors | FARMITALIA CARLO ERBA (IT) | 1994-10-18 | — | — | US | disclosed |
| EP-0616801-A1 | Process for preparing a liposome dispersion at high pressure | CIBA-GEIGY AG (CH) | 1994-09-28 | — | — | EP | disclosed |
| EP-0467838-A2 | Process for preparing an injectable liposome dispersion | CIBA-GEIGY AG (CH) | 1992-01-22 | — | — | EP | disclosed |